Krognes Steve E. sold $1.2M of GH
Krognes Steve E. sold 9,294 shares of Guardant Health, Inc. (GH) at $132.51 ($1.23M total) on 2026-06-04.
How this was made
The 30-second read
Why it matters
The key trading angle is whether the sale is interpreted as a bearish signal given it was not under a pre-arranged 10b5-1 plan; however, insider sales alone rarely drive sustained repricing without accompanying fundamental news.
Market read
A single director sale worth ~$1.23M may slightly pressure sentiment, but there is no new operational/financial catalyst in the filing.
What to watch
The article lacks context on prior insider activity frequency, option exercises, tax events, and whether the director retains meaningful exposure post-sale.
Background
This is an SEC Form 4 insider transaction disclosure for Guardant Health, Inc. (GH).
Ticker impact
Guardant Health director Steve E. Krognes sold 9,294 shares in an open-market transaction worth about $1.23M, disclosed via SEC Form 4.
Low near-term impact; any effect is likely sentiment-driven and short-lived.
The filing provides a specific sale price/size and confirms it was not under a pre-arranged 10b5-1 plan, which can increase interpretive sensitivity, but it does not include new company fundamentals.
Market effects
Minimal; this is company-specific insider activity with no stated sector-wide development.
None indicated.
None indicated.
Counterpoint
Non-10b5-1 sales can be routine liquidity/portfolio rebalancing and may not reflect negative expectations.
Key entities
- companyGuardant Health, Inc.
Issuer of the SEC Form 4 insider transaction; director sold 9,294 shares at ~$132.51.
- personSteve E. Krognes
Director who executed the open-market sale; holdings after transaction were 10,222 shares.
